Argenica Therapeutics LtdASX: AGN

Topline Phase 2 Trial Results of ARG-007 in AIS Patients

Sep 3, 2025 at 3:55 AM UTC · Issued by Argenica Therapeutics Ltd

Argenica Therapeutics Ltd has released a press release.

View Attachment